Development and validation of a patient satisfaction and preference questionnaire for inhalation devices

Treatments in Respiratory Medicine

Volumn 4, Issue 1, 2005, Pages 41-52

  Kozma, Chris M ^a   Slaton, Terry L ^b   Monz, Brigitta U ^c   Hodder, Richard ^d   Reese, Pat R ^e  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Independent Pharmaceut Consultant   (United States)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d UNIVERSITY OF OTTAWA   (Canada)

^e Reese Associates Consulting LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FENOTEROL PLUS IPRATROPIUM BROMIDE;

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; INHALATION SPACER; INHALER; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; MEDICAL LITERATURE; METERED DOSE INHALER; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; STATISTICAL ANALYSIS; STATISTICAL DISTRIBUTION; VALIDATION PROCESS;

ADULT; ASTHMA; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; PATIENT SATISFACTION; PSYCHOMETRICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 14944356286     PISSN: 11763450     EISSN: None     Source Type: Journal    
DOI: 10.2165/00151829-200504010-00005     Document Type: Article

References (39)

1. Duerden M, Price D. Training issues in the use of inhalers. Dis Manage Health Outcomes 2001; 9: 75-87
2. Pavia D. Efficacy and safety of inhalation therapy in chronic obstructive pulmonary disease and asthma. Respirology 1997; 2 Suppl. 1: S5-10
3. Ganderton D. Targeted delivery of inhaled drugs: current challenges and future goals. J Aerosol Med 1999; 12 Suppl. 1: S3-8
4. Lotvall J, O'Byrne P. Targeting drugs to the airways by different inhalation devices. BioDrugs 1999; 12: 279-89
5. Geller DE. New liquid aerosol generation devices: systems that force pressurized liquids through nozzles. Respir Care 2002; 47: 1392-404
6. Newman SP, Brown J, Steed KP, et al. Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of Respimat with conventional metered-dose inhalers with and without spacer devices. Chest 1998; 113: 957-63
7. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002; 19: 246-51
8. Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004; 2: 12
9. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 2004; 7: 204-15
10. Boe J, Stiksa G, Svensson K, et al. New method of evaluating patient preference for different inhalation delivery systems. Ann Allergy 1992; 68: 255-60
11. Schlaeppi M, Edwards K, Fuller RW, et al. Patient perception of the Diskus inhaler: a comparison with the Turbuhaler inhaler. Br J Clin Pract 1996; 50: 14-9
12. Nielsen K, Okamoto L, Shah T. Importance of selected inhaler characteristics and acceptance of a new breath-actuated powder inhalation device. J Asthma 1997; 34: 249-53
13. Mahajan P, Okamoto L. Patient satisfaction with the Diskhaler and the Diskus inhaler, a new multidose power delivery system for the treatment of asthma. Clin Ther 1997; 19: 1126-34
14. van der Palen J, Klein JJ, Schildkamp AM. Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use. J Asthma 1998; 35: 147-52
15. Liam CK, Lim KH, Wong CM. Acceptance of the Accuhaler, a multi-dose powder inhaler, among asthmatic patients: a comparison with the pressurized metered-dose inhaler. Asian Pac J Allergy Immunol 2000; 18: 135-40
16. Brown PH, Lenney J, Armstrong S, et al. Breath-actuated inhalers in chronic asthma: comparison of Diskhaler and Turbohaler for delivery of beta-agonists. Eur Respir J 1992; 5: 1143-5
17. Bronsky EA, Debelic M, Pujet JC, et al. Ease-of-use study of pirbuterol acetate in the Autohaler actuator in three countries: the United States, Germany, and France. J Asthma 1993; 30: 439-43
18. Chapman KR, Love L, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest 1993; 104: 1332-7
19. Kesten S, Elias M, Cartier A, et al. Patient handling of a multidose dry powder inhalation device for albuterol. Chest 1994; 105: 1077-81
20. Boulet LP, Cowie R, Johnston P, et al. Comparison of Diskus inhaler, a new multidose powder inhaler, with Diskhaler inhaler for the delivery of salmeterol to asthmatic patients. Canadian Study Group. J Asthma 1995; 32: 429-36
21. Gioulekas D, Papakosta D, Vordoyianni P, et al. A comparison of the clinical efficacy and patient acceptability of terbutaline Turbuhaler and salbutamol Rotahaler, in adult patients with asthma. Respir Med 1996; 90: 205-9
22. O'Reilly JF, Weir DC, Banham S, et al. Is high-dose fluticasone propionate via a metered-dose inhaler and Volumatic as efficacious as nebulized budesonide in adult asthmatics? Respir Med 1998; 92: 111-7
23. Pieters WR, Stallaert RA, Prins J, et al. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microgram twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients. J Asthma 1998; 35: 337-45
24. Balzano G, Battiloro R, Biraghi M, et al. Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. J Aerosol Med 2000; 13: 25-33
25. Kunkel G, Schaper C, Noga O, et al. Efficacy, safety, and acceptance of beclomethasone dipropionate administered via a new dry powder inhaler or a standard CFC metered-dose inhaler in asthma patients. Respiration 2003; 70: 399-406
26. Frew AJ, Langley SJ, Perrin V, et al. Effects of 4-week treatment with low-dose budesonide (100 micrograms BID) from a novel inhaler Airmax and from a conventional inhaler on bronchial hyper-responsiveness, lung function and symptoms in patients with mild asthma. Respir Med 2002; 96: 542-7
27. Tukiainen H, Rytila P, Hamalainen KM, et al. Safety, tolerability and acceptability of two dry powder inhalers in the administration of budesonide in steroid-treated asthmatic patients. Respir Med 2002; 96: 221-9
28. Jager L, Laurikainen K, Leinonen M, et al. Beclomethasone dipropionate Easyhaler is as effective as budesonide Turbohaler in the control of asthma and is preferred by patients. German Study Group. Int J Clin Pract 2000; 54: 368-72
29. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003; 56: 395-407
30. Schürmann W, Schmidtmann S, Moroni P, et al. Respimat® Soft Mist™ inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction. Treat Respir Med 2005; 4 (1): 53-61
31. Ware J, Harris W, Gandek B, et al. MAP-R for Windows. Multitrait/multi-item analysis program: revised user's guide. Boston (MA): Health Assessment Lab., 1997
32. Hand CH. Developing a questionnaire to measure patients' beliefs about inhaler treatment: a pilot study. Asthma Gen Pract 1998; 6: 40-3
33. Williams J, Richards KA. Ease of handling and clinical efficacy of fluticasone propionate Accuhaler/Diskus inhaler compared with the Turbohaler inhaler in paediatric patients. Br J Clin Pract 1997; 51: 147-53
34. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994; 47: 81-7
35. Guyatt GH, Osoba D, Wu AW, et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002; 77: 371-83
36. Kelleher CJ, Pleil AM, Reese PR, et al. How much is enough and who says so? BJOG 2004; 111: 605-12
37. Wyrwich KW, Nienaber NA, Tierney WM, et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999; 37: 469-78
38. Novak A, de la Loge C, Abetz L. Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing. Pharmacoeconomics 2004; 22: 245-56
39. Welch MJ, Nelson HS, Shapiro G, et al. Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers. J Aerosol Med 2004; 17: 129-39